The global Artificial Intelligence (AI) in healthcare market, valued at US$14.92 billion in 2024, stood at US$21.66 billion in 2025 and is projected to advance at a resilient CAGR of 38.6% from 2025 to 2030, culminating in a forecasted valuation of US$110.61 billion by the end of the period.
The rapid proliferation of AI in the healthcare sector, the rising need for early disease detection, and the growing need for improvised healthcare services are the key factors driving market growth.
Strategic partnerships and collaborations among healthcare companies and AI technology providers are expected to provide lucrative opportunities for market players.
Growth in the North American market can be attributed to the high per capita healthcare expenditure, ongoing technological developments, and large number of diagnostic procedures.
Concerns regarding data privacy and the lack of interoperability between AI solutions offered by different vendors are expected to challenge the growth of this market.